| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.001 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |